Josie Review 2026
Reviewed August 8, 2026 · Primarily compounded semaglutide and tirzepatide in injection and ODT formats, plus brand-name Ozempic and compounded HRT. Compounded medications are not FDA-approved.
Visit Josie WebsiteOverview
Josie is a women's telehealth service built around perimenopause and menopause, offering three pathways — hormone replacement therapy from $89 a month, full-dose GLP-1 weight management from $194, and a 'microdose maintenance' protocol at $189 — and it is one of the few providers in this directory that publishes the price of every single medication and format before you enter an intake. Compounded semaglutide injection is $194, semaglutide ODT $226, tirzepatide injection $233, tirzepatide ODT $242, with brand-name Ozempic also listed. Offering oral disintegrating tablets alongside injections is genuinely useful: needle aversion is a real reason people never start, and most competitors offer no alternative. What stands out more is the language. Josie writes that providers 'may discuss HRT, GLP-1, or microdose maintenance care when appropriate', that 'a licensed provider reviews your intake before any care is prescribed', and that medication ships 'if care is prescribed'. That conditional phrasing is not accidental and it is the correct way to describe telehealth prescribing — compare it with competitors whose funnels imply approval is a formality. Combining hormone therapy and weight management under one provider also reflects clinical reality, since the metabolic changes of perimenopause and the symptoms treated by HRT arrive together. Our reservation is the microdose lane. Josie sells microdosed semaglutide and tirzepatide at $189 a month as a 'longevity' and maintenance protocol, and there is no established evidence base for GLP-1 microdosing — no approved indication, no dosing standard, and no trial data showing that sub-therapeutic doses deliver longevity benefits. Charging nearly as much for the microdose as for full-dose semaglutide, for a protocol with no efficacy evidence, is the weakest part of an otherwise careful operation.
Medications Offered
Brand-name or compounded: Primarily compounded semaglutide and tirzepatide in injection and ODT formats, plus brand-name Ozempic and compounded HRT. Compounded medications are not FDA-approved.
- Compounded semaglutide injection — from $194/month
- Compounded semaglutide ODT (oral disintegrating tablet) — from $226/month
- Compounded tirzepatide injection — from $233/month
- Compounded tirzepatide ODT — from $242/month
- Ozempic (brand-name semaglutide)
- Microdose semaglutide injection or ODT — $189/month
- Microdose tirzepatide injection or ODT — $189/month
- Hormone replacement therapy — from $89/month
Consultation Process
Complete your intake
An online intake covering symptoms, health history and goals, built specifically around perimenopause and menopause.
Provider review
A licensed Josie provider reviews the intake to determine whether HRT, full-dose GLP-1 or microdose maintenance care may be appropriate. Josie states no care is prescribed before this review.
Receive your plan
If care is prescribed, medication is shipped by a licensed pharmacy or compounding pharmacy with instructions.
Ongoing support
Continued contact with your provider for check-ins, dose adjustments and questions as the plan evolves.
Eligibility
- Women in perimenopause or menopause
- Adults; a licensed provider determines suitability from the intake
- Not for use in pregnancy or breastfeeding
- HRT requires individual assessment where there is a personal or family history of hormone-sensitive cancer, clotting disorders or stroke
- GLP-1s are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN2
- State availability is not published
Provider Involvement
Well described in structure, thin on identity. Josie states a licensed provider reviews every intake before any prescribing decision, and that ongoing check-ins and dose adjustments run through that provider. What is not published is who the providers are, their credentials, or which states they are licensed in. For a service treating both hormone therapy and metabolic medicine, naming the clinical leadership would strengthen it considerably.
Lab Requirements
Not published. This matters more here than at a pure GLP-1 provider: hormone therapy decisions are generally improved by baseline levels, and menopausal symptoms overlap with thyroid disease and anaemia, both of which a blood panel identifies. Ask what testing is done before and during treatment.
Pharmacy Fulfillment
Josie states medication is shipped by 'a licensed pharmacy or compounding pharmacy', which is more disclosure than many offer but stops short of naming the facility or stating whether compounding is 503A or 503B. Given most of the catalogue is compounded, that is the gap worth closing.
Shipping Frequency
Monthly supply shipped after provider review, with ongoing check-ins.
Membership Fees vs. Medication Fees
Membership fees
No separate membership fee is advertised — the monthly medication price is the quoted cost. Confirm at checkout whether any consultation or platform fee applies.
Medication fees
- Compounded semaglutide injection: from $194/month
- Compounded semaglutide ODT: from $226/month
- Compounded tirzepatide injection: from $233/month
- Compounded tirzepatide ODT: from $242/month
- Microdose protocols (any format): $189/month
- HRT: from $89/month
- Up to $100 off via the intake quiz
Cancellation & Refund Policy
Cancellation
Not published on the pages we examined. Josie publishes terms of service and a privacy policy; get the cancellation terms and any minimum commitment in writing before your first charge.
Refunds
Not published. Confirm before ordering.
Insurance
Not stated as accepted. Compounded medication cannot generally be billed to a pharmacy benefit, so assume cash-pay unless Josie confirms otherwise for the brand-name Ozempic option.
HSA / FSA
Not stated. Ask directly — compounded medication eligibility varies by plan administrator.
See our GLP-1 insurance and HSA/FSA guide for how reimbursement works in practice.
Support Services
- Provider check-ins and dose adjustments
- Three-step matching quiz with no email required
- HRT, weight management and maintenance pathways under one service
- ODT formats for patients who cannot inject
State Availability
Not published. Confirm your state before starting the intake.
Pros
- Publishes a complete price list for every medication and format before you sign up
- Unusually careful language — 'may discuss', 'when appropriate', 'if care is prescribed'
- States a licensed provider reviews your intake before anything is prescribed
- Built specifically for perimenopause and menopause rather than treating women as a segment
- Offers oral disintegrating tablet (ODT) formats for people who cannot or will not inject
- Combines HRT and GLP-1 pathways under one provider, which matters at this life stage
- Discloses that medication ships from 'a licensed pharmacy or compounding pharmacy'
- Ongoing check-ins and dose adjustments are part of the stated model
Cons
- Microdose GLP-1 protocols at $189/month have no established evidence base
- Microdosing is marketed for 'longevity', a claim no GLP-1 is approved for
- The compounding pharmacy is not named and 503A/503B status is not stated
- GLP-1 pricing is mid-market — $194-$242/month is above the cheapest flat-rate rivals
- '5,000+ members' is self-reported
- No published lab requirements, which matters more for HRT than for GLP-1s
- State availability is not listed
Who Josie May Be Best For
- Women in perimenopause or menopause who want hormone and weight care from one provider
- Anyone who wants to see the full price list before entering an intake
- People who cannot or will not self-inject and need an oral option
Limitations
- Microdose 'longevity' protocol has no evidence base
- Compounding pharmacy unnamed
- No published cancellation, refund or lab requirements
- Mid-market pricing rather than lowest cost
- No state availability list
Reputation & Trust
Josie does two things that most of this market does not. It publishes a complete price list — every medication, every format, before you enter a funnel — so you can compare $194 semaglutide injection against $226 for the ODT and $233 for tirzepatide without surrendering an email address. And it writes about prescribing with genuine care: providers 'may discuss' options 'when appropriate', a licensed provider 'reviews your intake before any care is prescribed', and medication ships only 'if care is prescribed'. That conditional grammar is the honest description of what telehealth prescribing is, and it stands out against competitors whose funnels treat approval as a foregone conclusion. Offering oral disintegrating tablets alongside injections is a real accessibility feature, and running HRT and GLP-1 pathways together reflects how perimenopausal metabolic change and menopausal symptoms actually present. The reservations are specific rather than general. The microdose maintenance protocol at $189 a month is sold for 'longevity', and there is no approved indication, no dosing standard and no trial evidence establishing that sub-therapeutic GLP-1 doses deliver longevity or maintenance benefits — charging within $5 of full-dose semaglutide for it is hard to justify on evidence. The compounding pharmacy is unnamed with no 503A/503B disclosure. Cancellation and refund terms are not published, and neither are lab requirements, which matters for the HRT side. Pricing is also mid-market rather than cheap. But the disclosure culture here is better than most, and that counts.
What Makes Josie Different
- Complete published price list across every medication and format
- Consistently conditional, honest prescribing language
- ODT formats for patients who will not inject
- HRT and GLP-1 care from one provider at the same life stage
Our Verdict
Josie earns 4/5, and the score rests on disclosure. It publishes the price of every medication in every format — $194 semaglutide injection, $226 the ODT, $233 tirzepatide injection, $242 the ODT, $89 HRT — before you enter an intake or hand over an email address, which almost nobody in this market does. Its prescribing language is consistently and correctly conditional: providers 'may discuss' options 'when appropriate', and medication ships only 'if care is prescribed'. It offers oral disintegrating tablets for people who will not inject, and it treats perimenopausal metabolic change and menopausal symptoms as the connected problem they are rather than as two products. Against that, the microdose 'longevity' protocol at $189 a month is selling something with no approved indication, no dosing standard and no supporting trial evidence, at a price within $5 of full-dose semaglutide — and the compounding pharmacy goes unnamed with no 503A/503B disclosure, while cancellation, refund and lab requirements are all unpublished. Stick to the full-dose pathways, ask which pharmacy fills your prescription, and this is one of the more honest women's telehealth services we have reviewed.
Alternatives to Josie
Menopause care that takes insurance and states its compounded medication comes from 503B-accredited pharmacies.
Another menopause-focused service for direct comparison on HRT pricing and scope.
Bioidentical HRT telehealth if hormone therapy rather than weight is the priority.
If GLP-1 cost is the deciding factor, an all-inclusive plan from $99 with named pharmacy partners.
Compare more options on our best online GLP-1 providers and cheapest GLP-1 programs pages.
Frequently Asked Questions
Is GLP-1 microdosing worth $189 a month?
We would not pay it. Josie sells microdosed semaglutide and tirzepatide at $189 a month as a maintenance and 'longevity' protocol, in both injection and ODT formats. The difficulty is that GLP-1 microdosing has no established evidence base — there is no approved indication, no agreed dosing standard, and no trial data showing that sub-therapeutic doses produce longevity benefits or superior maintenance compared with tapering, stopping, or simply staying on an appropriate dose. Note also that $189 is within $5 of the full-dose compounded semaglutide injection at $194. If maintenance after weight loss is your goal, that is a conversation to have with a clinician about evidence-based options, not a product to buy on the strength of the word 'longevity'.
What is an ODT and why would I choose one?
An oral disintegrating tablet dissolves in the mouth rather than being injected. Josie offers ODT versions of both semaglutide and tirzepatide, at $226 and $242 a month against $194 and $233 for the injections. The case for them is straightforward: needle aversion stops a meaningful number of people from ever starting GLP-1 therapy, and most providers offer no alternative. The caveat is that compounded ODT formulations are not FDA-approved and their absorption is not established the way an approved oral semaglutide product's would be — you are paying roughly $30 a month more for a format whose bioavailability has not been characterised in the way the injectable route has.
How much does Josie cost in total?
Checked 8 August 2026: HRT from $89/month; compounded semaglutide injection from $194; semaglutide ODT from $226; tirzepatide injection from $233; tirzepatide ODT from $242; and any microdose protocol at $189. Brand-name Ozempic is also listed. The intake quiz offers up to $100 off and requires no email. No separate membership fee is advertised, but cancellation and refund terms are not published, so confirm those and any minimum commitment before your first charge.
Is the medication FDA-approved?
Mostly not. Apart from the brand-name Ozempic option, Josie's GLP-1 catalogue is compounded semaglutide and tirzepatide, and compounded medications are not FDA-approved and are not therapeutically equivalent to Ozempic, Wegovy, Mounjaro or Zepbound. Josie states medication ships from 'a licensed pharmacy or compounding pharmacy' but does not name the facility or say whether compounding is done under 503A or 503B rules. 503B outsourcing facilities operate under current good manufacturing practice requirements that 503A pharmacies do not, so it is worth asking which applies.
Should I take HRT and a GLP-1 at the same time?
That is a decision for a clinician who knows your full history, and the fact that Josie can prescribe both is a practical convenience rather than a clinical endorsement of combining them. There are real reasons the two arise together — the metabolic shift of perimenopause and the symptoms treated by HRT often appear in the same years. There are also reasons for care: hormone therapy has its own risk profile around clotting and hormone-sensitive cancers, GLP-1s have gastrointestinal effects that can influence absorption of oral medication, and starting two things at once makes it harder to attribute either benefit or side effect. Ask to start one and add the other, and ask what monitoring applies to each.
Important Notes & Warnings
- This review is informational only and is not medical advice.
- Compounded semaglutide and tirzepatide are NOT FDA-approved and are not therapeutically equivalent to Ozempic, Wegovy, Mounjaro or Zepbound.
- GLP-1 microdosing for 'longevity' or maintenance has NO established evidence base, no approved indication and no agreed dosing standard.
- GLP-1 medications carry a boxed warning for thyroid C-cell tumours in rodents and are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN2.
- Hormone replacement therapy carries its own risks including clotting and, depending on formulation and history, hormone-sensitive cancers. A personal or family history of breast cancer, blood clots, stroke or liver disease requires individual assessment.
- Do not use in pregnancy or while breastfeeding.
- Compounded ODT formulations have not had their absorption characterised the way approved products have.
- The compounding pharmacy is not named and 503A/503B status is not disclosed. Ask before ordering.
- Cancellation and refund terms are not published. Get them in writing before your first charge.
Sources
- Josie homepage, care pathways and published price list, joinjosie.com (rendered via headless browser, accessed 8 August 2026) — all pricing, the four-step process, pharmacy disclosure and membership figure
- Josie terms of service and privacy policy (accessed 8 August 2026)
Medical Disclaimer
This review is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with real risks and contraindications. Only a licensed clinician who has evaluated you can decide whether any medication is appropriate. Talk to a healthcare provider before starting, changing, or stopping any treatment, and call emergency services for urgent symptoms.
Facts in this review were compiled from the provider's own public website and public search results as of August 8, 2026. Prices, medication availability, pharmacy partners, and policies change frequently and vary by state — verify everything directly with the provider before purchasing.
This page contains affiliate links. We may earn a commission from qualifying purchases at no additional cost to you.